EMA: parent whenever possible [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-09-20 14:53 (4253 d 08:42 ago) – Posting: # 11531
Views: 29,518

Hi CR,

❝ So, do you recommend analysing both Spironolactone and the metabolites? If so, BE criteria (for MHRA) will be based on parent or both?


If you reliably can measure spironolactone, there is no need to measure any of its metabolites.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
136 visitors (0 registered, 136 guests [including 8 identified bots]).
Forum time: 23:35 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5